Haemonetics Corporation is downgraded to Hold after a sharp share price surge and expanded CSL Plasma agreement. Read more on ...

AMD remains a buy after a 30% rally, with significant runway for revenue and margin expansion driven by strong CPU demand and ...

An updated MacBook Pro with the M6 chip is expected to arrive sometime this fall, based on its usual upgrade cycle. But rumor ...

Exchange Income Corporation (TSX: EIF) (EIC or the Corporation), a diversified, acquisition-oriented company focused on opportunities in the Aerospace & Aviation and Manufacturing segments, ...

That is where monolithic and microservices architecture come in. Neither is universally better. A monolith often suits a ...

Dublin, Oct. 09, 2026 (GLOBE NEWSWIRE) -- "Mobile Robots Market, till 2035: Distribution by Type of Offering, Type of Robot, Payload, Navigation Mode, Form Factor, Type of Enterprise, Distribution ...

Compare Amazon's Alexa Tablet 12 Pro and iPad Air M4 on price, displays, apps, AI, performance, and accessories to pick the ...

XMax is acquiring Hexa Creation to extend its AI strategy into power infrastructure for AI computing and other high-voltage ...

Discover ArtCraft's seven free creative apps for Windows, macOS, and Linux, including open-source alternatives for image ...

I am Toda, an executive officer at Henry Inc. As a Registered Information Security Specialist (Registration No. 028693), a ...

Cell Therapy Monitoring Kits Market was valued at USD 2.26 billion in 2025 and is expected to reach USD 4.35 billion by 2035, growing at a CAGR of 6.81% from 2026-2035.

Here, we highlight three medical product stocks, ICUI, NEOG and TRLV, which are well positioned to benefit from industry tailwinds and could be worth adding to investors' portfolios.